Hafiz Muhammad Waqas Khan (Hafiz Khan)

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 6

Top Topics

Percutaneous Coronary Intervention

St Segment Elevation Myocardial Infarction

Top Venues

European heart journal. Case reports

Proceedings (Baylor University. Medical Center)

American journal of cardiovascular drugs : drugs, devices, and other interventions

SAGE open medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Hafiz Muhammad Waqas Khan, Amman Yousaf, Muhammad Ahmad, Hameem U Changezi
Gas in the myocardium: a fatal presentation of Clostridium perfringens : a case report. European heart journal. Case reports 7 (1) (2023)
Hafiz Muhammad Waqas Khan, Amman Yousaf, Muhammad Ahmad, Hameem U Changezi
Gas in the myocardium: a fatal presentation of Clostridium perfringens : a case report. European heart journal. Case reports 7 (1) (2023)
Hafiz Muhammad Waqas Khan, Ahmad Munir, Anup Sud, Ankush Moza
Heart in a shell-a cascade of classical findings: a case report. European heart journal. Case reports 6 (6) (2022)
Muhammad Ahmad, Amman Yousaf, Hafiz Muhammad Waqas Khan, Ahmad Munir, Arul Chandran
Mycobacterium chimaera lung infection and empyema in a patient without cardiopulmonary bypass. Proceedings (Baylor University. Medical Center) 35 (6) (2022)
Basel Abdelazeem, Joseph Shehata, Kirellos Said Abbas, Nahla Ahmed El-Shahat, Nischit Baral, Govinda Adhikari, Hafiz Muhammad Waqas Khan, Mustafa Hassan
De-escalation from Prasugrel or Ticagrelor to Clopidogrel in Patients with Acute Coronary Syndrome Managed with Percutaneous Coronary Intervention: An Updated Meta-analysis of Randomized Clinical Trials. American journal of cardiovascular drugs : drugs, devices, and other interventions (2021)
Sakiru Oyetunji Isa, Olajide Buhari, Muminat Adeniran-Isa, Mahin Khan, Hafiz Muhammad Waqas Khan, Raghunandan Konda, Hameem Changezi, Luis Afonso
In-hospital outcomes after percutaneous coronary interventions in cardiac allograft recipients. SAGE open medicine 9 (2021)